U.S. License Holder:
Allergan
Date of License:
August-27-2009
Last Update:
Sep-23-2023
FDA-Approved Indications
ZENPEP (pancrelipase (amylase; lipase; protease)) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, or other conditions.